BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32767285)

  • 1. Glucagon and Liver Fat are Downregulated in Response to Very Low-calorie Diet in Patients with Obesity and Type-2 Diabetes.
    Haas SL; Löfgren P; Stål P; Hoffstedt J
    Exp Clin Endocrinol Diabetes; 2022 Jan; 130(1):55-60. PubMed ID: 32767285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
    Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a carbohydrate-free diet vs. fasting on plasma glucose, insulin and glucagon in type 2 diabetes.
    Nuttall FQ; Almokayyad RM; Gannon MC
    Metabolism; 2015 Feb; 64(2):253-62. PubMed ID: 25458830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy].
    Tang W; Chen Y; Pan M; Chen L; Zhang L; Wang T; Zhang X; Zhang P; Zheng C; Yu B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):411-416. PubMed ID: 28440522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.
    Malandrucco I; Pasqualetti P; Giordani I; Manfellotto D; De Marco F; Alegiani F; Sidoti AM; Picconi F; Di Flaviani A; Frajese G; Bonadonna RC; Frontoni S
    Am J Clin Nutr; 2012 Mar; 95(3):609-13. PubMed ID: 22318758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes.
    Sathananthan M; Shah M; Edens KL; Grothe KB; Piccinini F; Farrugia LP; Micheletto F; Man CD; Cobelli C; Rizza RA; Camilleri M; Vella A
    J Nutr; 2015 Sep; 145(9):2046-51. PubMed ID: 26246321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
    Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
    Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of type 2 diabetes in youth who adhere to a very-low-energy diet: a pilot study.
    Gow ML; Baur LA; Johnson NA; Cowell CT; Garnett SP
    Diabetologia; 2017 Mar; 60(3):406-415. PubMed ID: 27889809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
    Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
    Cunha GM; Guzman G; Correa De Mello LL; Trein B; Spina L; Bussade I; Marques Prata J; Sajoux I; Countinho W
    Front Endocrinol (Lausanne); 2020; 11():607. PubMed ID: 33042004
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.
    Petersen KF; Dufour S; Befroy D; Lehrke M; Hendler RE; Shulman GI
    Diabetes; 2005 Mar; 54(3):603-8. PubMed ID: 15734833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men.
    Khoo J; Piantadosi C; Duncan R; Worthley SG; Jenkins A; Noakes M; Worthley MI; Lange K; Wittert GA
    J Sex Med; 2011 Oct; 8(10):2868-75. PubMed ID: 21819545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.
    Steven S; Hollingsworth KG; Al-Mrabeh A; Avery L; Aribisala B; Caslake M; Taylor R
    Diabetes Care; 2016 May; 39(5):808-15. PubMed ID: 27002059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
    Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
    N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.
    Henry RR; Wiest-Kent TA; Scheaffer L; Kolterman OG; Olefsky JM
    Diabetes; 1986 Feb; 35(2):155-64. PubMed ID: 3510922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Calorie Restriction Maintains Plasma Insulin Concentrations along with a Reduction in Hepatic Insulin-Degrading Enzyme Levels in db/db Mice.
    Nonaka Y; Takeda R; Kano Y; Hoshino D
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial.
    Fontes-Villalba M; Lindeberg S; Granfeldt Y; Knop FK; Memon AA; Carrera-Bastos P; Picazo Ó; Chanrai M; Sunquist J; Sundquist K; Jönsson T
    Cardiovasc Diabetol; 2016 May; 15():80. PubMed ID: 27216013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.